251 related articles for article (PubMed ID: 31608054)
21. Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies.
Watanabe H; Sada KE; Matsumoto Y; Harigai M; Amano K; Dobashi H; Fujimoto S; Usui J; Yamagata K; Atsumi T; Banno S; Sugihara T; Arimura Y; Matsuo S; Makino H;
Arthritis Rheumatol; 2018 Oct; 70(10):1626-1633. PubMed ID: 29790303
[TBL] [Abstract][Full Text] [Related]
22. Predicting factors for relapse in patients with granulomatosis with polyangiitis: results from a long-term cohort.
Mehrabi Nejad MM; Jazayeri SB; Ayoobi Yazdi N; Afshar A; Alesaeidi S
Clin Rheumatol; 2022 Aug; 41(8):2457-2465. PubMed ID: 35397719
[TBL] [Abstract][Full Text] [Related]
23. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
[TBL] [Abstract][Full Text] [Related]
24. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
de Joode AAE; Sanders JSF; Puéchal X; Guillevin LP; Hiemstra TF; Flossmann O; Rasmussen N; Westman K; Jayne DR; Stegeman CA
Rheumatology (Oxford); 2017 Nov; 56(11):1894-1901. PubMed ID: 28977502
[TBL] [Abstract][Full Text] [Related]
25. CD19
Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
[TBL] [Abstract][Full Text] [Related]
26. Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).
Charles P; Terrier B; Perrodeau É; Cohen P; Faguer S; Huart A; Hamidou M; Agard C; Bonnotte B; Samson M; Karras A; Jourde-Chiche N; Lifermann F; Gobert P; Hanrotel-Saliou C; Godmer P; Martin-Silva N; Pugnet G; Matignon M; Aumaitre O; Viallard JF; Maurier F; Meaux-Ruault N; Rivière S; Sibilia J; Puéchal X; Ravaud P; Mouthon L; Guillevin L;
Ann Rheum Dis; 2018 Aug; 77(8):1143-1149. PubMed ID: 29695500
[TBL] [Abstract][Full Text] [Related]
27. Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis.
Szczeklik W; Jakieła B; Wawrzycka-Adamczyk K; Sanak M; Hubalewska-Mazgaj M; Padjas A; Surmiak M; Szczeklik K; Sznajd J; Musiał J
Eur J Immunol; 2017 Apr; 47(4):724-733. PubMed ID: 28155222
[TBL] [Abstract][Full Text] [Related]
28. Evidence for enhanced Bruton's tyrosine kinase activity in transitional and naïve B cells of patients with granulomatosis with polyangiitis.
von Borstel A; Abdulahad WH; Sanders JS; Rip J; Neys SFH; Hendriks RW; Stegeman CA; Heeringa P; Rutgers A; Corneth OBJ
Rheumatology (Oxford); 2019 Dec; 58(12):2230-2239. PubMed ID: 31209475
[TBL] [Abstract][Full Text] [Related]
29. CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease.
de Masson A; Bouaziz JD; Le Buanec H; Robin M; O'Meara A; Parquet N; Rybojad M; Hau E; Monfort JB; Branchtein M; Michonneau D; Dessirier V; Sicre de Fontbrune F; Bergeron A; Itzykson R; Dhédin N; Bengoufa D; Peffault de Latour R; Xhaard A; Bagot M; Bensussan A; Socié G
Blood; 2015 Mar; 125(11):1830-9. PubMed ID: 25605369
[TBL] [Abstract][Full Text] [Related]
30. HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study.
Lee SW; Kim DY; Ahn SH; Park YB; Han KH; Park JY
Rheumatol Int; 2018 Aug; 38(8):1531-1538. PubMed ID: 29754328
[TBL] [Abstract][Full Text] [Related]
31. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
[TBL] [Abstract][Full Text] [Related]
32. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.
Rasmussen N; Salmela A; Ekstrand A; de Groot K; Gregorini G; Cohen Tervaert JW; Gross WL; Wiik A; Jayne DR;
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S38-44. PubMed ID: 23380137
[TBL] [Abstract][Full Text] [Related]
33. Is serum HMGB1 a biomarker in ANCA-associated vasculitis?
de Souza A; Westra J; Bijzet J; Limburg PC; Stegeman CA; Bijl M; Kallenberg CG
Arthritis Res Ther; 2013; 15(5):R104. PubMed ID: 24007972
[TBL] [Abstract][Full Text] [Related]
34. IgG4:IgG RNA ratio differentiates active disease from remission in granulomatosis with polyangiitis: a new disease activity marker? A cross-sectional and longitudinal study.
Al-Soudi A; Doorenspleet ME; Esveldt RE; Burgemeister LT; Hak AE; van den Born BJH; Tas SW; van Vollenhoven RF; Klarenbeek PL; de Vries N
Arthritis Res Ther; 2019 Jan; 21(1):43. PubMed ID: 30704507
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.
Hazebroek MR; Kemna MJ; Schalla S; Sanders-van Wijk S; Gerretsen SC; Dennert R; Merken J; Kuznetsova T; Staessen JA; Brunner-La Rocca HP; van Paassen P; Cohen Tervaert JW; Heymans S
Int J Cardiol; 2015 Nov; 199():170-9. PubMed ID: 26209947
[TBL] [Abstract][Full Text] [Related]
36. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
[TBL] [Abstract][Full Text] [Related]
37. Granulomatosis with polyangiitis and facial palsy: Literature review and insight in the autoimmune pathogenesis.
Iannella G; Greco A; Granata G; Manno A; Pasquariello B; Angeletti D; Didona D; Magliulo G
Autoimmun Rev; 2016 Jul; 15(7):621-31. PubMed ID: 26851550
[TBL] [Abstract][Full Text] [Related]
38. Antineutrophil cytoplasmic antibodies and their relationship with disease activity and presence of staphylococcal superantigens in nasal swabs in patients having granulomatosis with polyangiitis: results of a study involving 115 patients from a single center.
Fijolek J; Wiatr E; Petroniec V; Augustynowicz-Kopec E; Bednarek M; Gawryluk D; Roszkowski-Sliz K
Clin Rheumatol; 2019 Nov; 38(11):3297-3305. PubMed ID: 31338700
[TBL] [Abstract][Full Text] [Related]
39. Seasonal Influence on the Risk of Relapse at a Rise of Antineutrophil Cytoplasmic Antibodies in Vasculitis Patients with Renal Involvement.
Kemna MJ; Cohen Tervaert JW; Broen K; Timmermans SAMEG; van Paassen P; Damoiseaux JGMC
J Rheumatol; 2017 Apr; 44(4):473-481. PubMed ID: 28202741
[TBL] [Abstract][Full Text] [Related]
40. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
